Early Experience with the Biotronik Protego ICD Lead.
Thomas SeilerChristian GrebmerGabriela HilfikerRichard KobzaBenjamin BertePublished in: Journal of clinical medicine (2022)
In this retrospective observational study, the calculated annual lead failure rate of the Biotronik Protego ICD lead was 0.59% per patient-thus, the durability and long-term performance seem to be promising.
Keyphrases